Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Element Solutions | ESI | Aug 30, 2024 | 26.74 | +0.87 |
Elevai Labs | ELAB | Aug 30, 2024 | 0.27 | -0.71 |
Elevance Health | ELV | Aug 30, 2024 | 556.89 | +0.87 |
Elevation Oncology | ELEV | Aug 30, 2024 | 0.78 | +2.34 |
Eli Lilly | LLY | Aug 30, 2024 | 960.02 | +2.11 |
Elicio Therapeutics | ELTX | Aug 30, 2024 | 3.80 | -5.00 |
Eliem Therapeutics | ELYM | Aug 30, 2024 | 6.99 | -5.03 |
Ellington Financial | EFC | Aug 30, 2024 | 13.15 | -0.53 |
Ellington Financial | EFC-B | Aug 30, 2024 | 21.79 | +1.35 |
Ellington Financial A Pref | EFC-A | Aug 30, 2024 | 25.28 | +1.73 |
Ellington Financial D Pref | EFC-D | Aug 30, 2024 | 21.96 | +1.55 |
Ellington Financial E Pref | EFC-E | Aug 30, 2024 | 25.62 | -0.50 |
Ellington Financial Pref | EFC-C | Aug 30, 2024 | 25.59 | +2.61 |
Ellington Residential Mortgage REIT | EARN | Aug 30, 2024 | 6.92 | -1.28 |
Ellomay Capital | ELLO | Aug 30, 2024 | 13.10 | +1.63 |
Ellsworth Growth | ECF | Aug 30, 2024 | 8.75 | 0.00 |
Ellsworth Growth A | ECF-A | Aug 30, 2024 | 22.84 | 0.00 |
Elme Communities | ELME | Aug 30, 2024 | 17.66 | +1.15 |
Eltek | ELTK | Aug 30, 2024 | 10.69 | +0.28 |
Elutia | ELUT | Aug 30, 2024 | 4.10 | 0.00 |
Embecta | EMBC | Aug 30, 2024 | 16.34 | -0.49 |
Embotelladora Andina ADR | AKO-B | Aug 30, 2024 | 19.32 | -1.28 |
Embotelladora Andina ADR | AKO-A | Aug 30, 2024 | 15.98 | -5.97 |
Embrace Change Acquisition | EMCG | Aug 30, 2024 | 11.55 | +0.35 |
Embrace Change Acquisition Unit | EMCGU | Aug 30, 2024 | 11.97 | +4.45 |
Embraer ADR | ERJ | Aug 30, 2024 | 33.23 | +0.76 |
EMCOR Group | EME | Aug 30, 2024 | 393.06 | +2.05 |
Emcore | EMKR | Aug 30, 2024 | 1.05 | -1.87 |
Emerald Holding | EEX | Aug 30, 2024 | 5.55 | +0.54 |
Emeren ADR | SOL | Aug 30, 2024 | 1.81 | -3.72 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.